SLC18A2 and Parkinson disease: VMAT2, a transporter crucial for the synaptic vesicular packaging of monoamines such as serotonin, norepinephrine, histamine, and dopamine, has emerged as an important target for PD treatment (Eiden and Weihe, 2011).